VRTX - 2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond
Investors have experienced a difficult past 12 months in the market, and even many household names in the investing world haven't escaped the downturn. That goes for Cathie Wood, CEO of Florida-based investment firm Ark Invest. Most of Wood's actively managed funds have lagged the market this year.
But not all of her firm's stock picks have. For instance, biotech giants Vertex Pharmaceuticals (NASDAQ: VRTX) and Incyte (NASDAQ: INCY) -- both of which feature in Wood's Ark Genomic Revolution ETF -- have outperformed the market over the past year.
Let's consider why both of these Cathie Wood stocks can still deliver solid returns.
For further details see:
2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond